US Stock Market Movement | Liquidia (LQDA.US) Shares Surge Over 25% in Early Trading After Settlement Agreement With UnitedHealthcare

Zhituo Caijing APP reported that on Wednesday, Liquidia (LQDA.US) surged more than 25% in early trading, now trading at $33.72. In terms of news, the company previously announced that it had reached a $380.7 million settlement agreement with United Therapeutics Corporation, putting an end to years of legal disputes surrounding its pulmonary arterial hypertension treatment product. The agreement, announced on Tuesday, resolves six pending lawsuits between the two parties. Additionally, the agreement allows Liquidia to continue selling its inhaled formulation for treating pulmonary arterial hypertension (PAH), YUTREPIA, without any interruption.